Clinical Trial Update: Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating semaglutide for alcohol use disorder in patients after metabolic and bariatric surgery; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Yale University | Conditions: Alcohol Use Disorder, Weight Loss | Phase 1 | Status: NOT_YET_RECRUITING